Waters Parkerson & Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Hold
2,152
0.01% 175
2026
Q1
$300K Hold
2,152
0.02% 165
2025
Q4
$264K Hold
2,152
0.01% 172
2025
Q3
$239K Hold
2,152
0.01% 171
2025
Q2
$239K Hold
2,152
0.01% 173
2025
Q1
$241K Buy
+2,152
New +$222K 0.01% 173
2018
Q1
Sell
-4,210
Closed -$302K 174
2017
Q4
$302K Hold
4,210
0.03% 140
2017
Q3
$341K Hold
4,210
0.03% 129
2017
Q2
$298K Sell
4,210
-1,000
-19% -$66.5K 0.03% 130
2017
Q1
$354K Sell
5,210
-1,350
-21% -$94.9K 0.03% 125
2016
Q4
$470K Sell
6,560
-50
-0.8% -$3.72K 0.05% 107
2016
Q3
$523K Sell
6,610
-102
-2% -$8.29K 0.05% 102
2016
Q2
$560K Buy
6,712
+600
+10% +$53.2K 0.06% 100
2016
Q1
$561K Sell
6,112
-284
-4% -$25.6K 0.06% 99
2015
Q4
$647K Buy
6,396
+350
+6% +$36.4K 0.07% 88
2015
Q3
$594K Buy
6,046
+101
+2% +$11.2K 0.08% 90
2015
Q2
$696K Hold
5,945
0.08% 88
2015
Q1
$583K Hold
5,945
0.07% 97
2014
Q4
$560K Buy
5,945
+225
+4% +$23.3K 0.07% 93
2014
Q3
$609K Buy
5,720
+700
+14% +$68.5K 0.07% 88
2014
Q2
$416K Hold
5,020
0.05% 103
2014
Q1
$356K Hold
5,020
0.04% 110
2013
Q4
$377K Buy
5,020
+1,060
+27% +$73.8K 0.05% 104
2013
Q3
$249K Buy
+3,960
New +$237K 0.03% 119

Other funds holding GILD

Waters Parkerson & Co's GILD Position: Q2 2026 in Review

Waters Parkerson & Co held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,152 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #175.

Waters Parkerson & Co first reported a position in GILD in Q3 2013 and has held it in 24 quarters since. The position peaked at $696K in Q2 2015. 1,429 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Waters Parkerson & Co held 2,152 shares of Gilead Sciences worth $272K as of Q2 2026.
  • Waters Parkerson & Co left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Waters Parkerson & Co's portfolio in Q2 2026, its #175 holding.
  • Waters Parkerson & Co first reported a position in Gilead Sciences in Q3 2013 and has held it in 24 quarters since.
  • Waters Parkerson & Co's Gilead Sciences position peaked at $696K in Q2 2015.
  • 1,429 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.